http://www.frost.com/prod/servlet/svcg.pag/HCPD - Pharmaceuticals and Biotechnology Research en-us Market Engineering Research Service The Research Service aims to analyse and assess the European market for Multiple Sclerosis. This is performed by analysing the key trends and dynamics shaping the industry sector in co-relation with the market drivers and restraints. With several key blockbuster drugs losing patent protection and new healthcare reforms introduced by governments, the Multiple Sclerosis market employs different trends like shift towards biologics which helps the market grow at a fairly steady pace. This research service provides an in-depth knowledge of the key European markets by presenting significant growth opportunities for the existing and the pipeline drugs with their impacts over market revenue contributed over a period of time. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M792-01-00-00-00 Tue, 31 Jan 2012 11:09:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M792-01-00-00-00 Market Engineering Research Service This research deliverable provides deep insights into the clinical development and outsourcing market in India. It also includes an overview of the Indian regulatory and R&D process briefing. It further highlights the key trends, drivers, and restraints of the clinical research market. The research deliverable also covers the forecast of the CRO market from 2008 to 2016. The research service also gives a deeper insight not only into the phase wise as well as therapy wise detail of the clinical trials. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=P5E8-01-00-00-00 Mon, 30 Jan 2012 03:19:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=P5E8-01-00-00-00 Market Engineering Research Service The primary objective of the study European Genetic Testing and Screening Services market is to assess the market potential of the current ongoing testing areas pertaining to the area of genetics such as diagnostic testing, relationship testing and predictive testing. Direct to consumer testing has received an immense attention and is creating the need to regulate the policies standards set for laboratories. Country wise predictions and their growth rates over the period 2010-2018 have been discussed for each segment. European regulations and the existing laws pertaining to genetic testing in the Western European countries have been discussed. A comprehensive list of 90 commercial test providers and manufacturers have been illustrated. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7D9-01-00-00-00 Mon, 30 Jan 2012 01:25:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7D9-01-00-00-00 Market Engineering Research Service This research service covers the United States glaucoma pharmaceuticals market from 2008 to 2016, with 2010 as the base year. Included in the study are products on the market and products in development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by classes of drug: prostaglandins, beta-blockers, alpha-adrenerigic agonists, carbonic anhydrase inhibitors, and fixed-dose combinations. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=NA6D-01-00-00-00 Fri, 27 Jan 2012 12:47:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=NA6D-01-00-00-00 Technical Insights Alert This issue profiles a simultaneous study of chromatin and DNA methylation in a microplate platform, improving cancer diagnostics and therapeutics through epigenetic applications, and plant cell expression-based protein therapeutics. Strategic partnership details and some important patents have also been included. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7F-00-00 Fri, 20 Jan 2012 02:39:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7F-00-00 Technical Insights Research Service Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies. Risks due to supply and distribution of fake /spurious drugs is also on the rise with many anti -counterfeit solutions being developed. This research service delves into the technology trends in pharmacovigilance and anti-counterfeit technologies and also discusses some of the recent activities and developments from every segment of the industry. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E5-01-00-00-00 Thu, 19 Jan 2012 04:58:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E5-01-00-00-00 Decision Support Database Burden of Disease or Conditions Decision Support Database provides information on exhaustive list of Measurements on Incidence, Prevalence and Mortality for different types of Communicable and Non Communicable Disease. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD31-00-01-00-00 Mon, 16 Jan 2012 00:55:34 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD31-00-01-00-00 Technical Insights Alert This issue profiles harnessing cellular senescence pathway for cancer therapeutics, biomarker discovery and drug profiling empowered by label-free phosphoproteomics, and a drug composition as therapeutic/vaccine for obesity and atherosclerosis. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-3A-00-00 Fri, 13 Jan 2012 05:52:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-3A-00-00 Technical Insights Alert This issue profiles a microarray platform for orphan receptors and ligands, a ligosachharide-based test for diagnosis and prognosis of MPS, and an antibody generating platform based on somatic hypermutation. Strategic partnership details and some important patents have also been included. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7E-00-00 Fri, 13 Jan 2012 04:37:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7E-00-00 Technical Insights Alert This issue profiles drug delivery systems for regenerative medicine, an electron model for enhancing particle therapy for cancer, and a new sensor technology for detecting deterioration of telecommunication cables. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D705-00-6C-00-00 Fri, 13 Jan 2012 01:21:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D705-00-6C-00-00 Technical Insights Alert This issue profiles an RNA-based expression system for vaccine development, a gene array that aids in diagnosis of anti-EGFR responsive mCRC, and using virus-like particles for counteracting against emerging pathogens. Strategic partnership details and some important patents have also been included. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7D-00-00 Fri, 6 Jan 2012 03:10:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7D-00-00 Market Engineering Research Service This research service analyses the emerging stem cell therapeutics applications by geographic regions, encompassing Europe - The United Kingdom, Germany, Sweden, Belgium, Finland, France and Spain. The study covers various areas of interest such as regulatory policies within stem cell research, emerging companies, key business updates, analysis of risk factors, and strategic recommendations. Small molecules and biologics like antibodies that aim to stimulate in vivo regenerative action, basic cell culture tools/media suppliers, gene therapy and non-stem cell-based therapy markets are not included in this study. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M737-01-00-00-00 Thu, 5 Jan 2012 00:38:56 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M737-01-00-00-00 Market Engineering Research Service http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=P5D0-01-00-00-00 Sat, 31 Dec 2011 01:28:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=P5D0-01-00-00-00 Market Engineering Research Service The Biologics Market in Brazil is facing a growing stage, being Monoclonal Antibodies the most significant segment. The Brazilian market is moving towards to became a highly regulated market and several patents of blockbusters are about to expire, causing changes in the biologics scenario. This research provides an analysis of Biologics market in Brazil, regarding to Monoclonal Antibodies, Blood Factors, Insulin, Filgrastin, Interferon, Growth Hormone and Erythropoietin. The base year of the study is 2010, and the forecast period is 2011 to 2016. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N8FD-01-00-00-00 Sat, 31 Dec 2011 01:21:32 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N8FD-01-00-00-00 Technical Insights Alert This issue profiles a fabric-based platform for rapid multiplexed diagnostics, a method for treating sickle cell anemia using patient's own cells, and using recombinant fibrinogen as a therapeutic tool for blood and bone diseases. Strategic partnership details and some important patents have also been included. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7C-00-00 Fri, 30 Dec 2011 05:57:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7C-00-00 Technical Insights Research Service The nucleic acid drugs sector consists of three major sub-sectors--aptamer therapeutics, antisense therapeutics, and RNA interference. Recent partnerships and alliances show an amalgamation of collaborations for discovery platforms and delivery technologies as well as drug entities. This report analyzes the R&D portfolio trends in these sub-sectors and then uses the Analytical Hierarchy Process (AHP) to prioritize different options that can be executed to design a strategic R&D portfolio,which showcases a company's innovation capacity and also leads to higher credibility among investors. Portfolio options have been prioritized on a disease basis which is the one commonly followed by both big pharmaceuticals and biotech companies. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2C6-01-00-00-00 Fri, 30 Dec 2011 05:57:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2C6-01-00-00-00 Technical Insights Research Service The research service brings out the emerging technology trends in automated microbiology space on a global scale with focus on clinical and pharmaceutical microbiology needs. The report provides impact analysis of major drivers and restraints influencing the adoption of automated microbiology, with a detailed assessment of technology adoption levels and demand side analysis. Further, the report covers emerging opportunity evaluation, AHP based prioritization of techniques for rapid pathogen detection and strategic recommendations along with technology management strategies and roadmap. Finally, a list of key patents provide an insight into notable developmental activities receiving funding along with a database of global participants. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E4-01-00-00-00 Fri, 30 Dec 2011 00:37:48 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E4-01-00-00-00 Decision Support Database Healthcare Expenditure - Decision Support Database focuses on expenditure status of different countries across regions. This database presents fundamental healthcare indicators that aim to explain the wound management capabilities of nations. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD06-00-02-00-00 Thu, 29 Dec 2011 08:26:37 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD06-00-02-00-00 Decision Support Database Industry - Decision Support Database focuses on the Biotech Market Structure, growth, investments of different countries across regions. Measurement in this Decision Support Database helps to understand the level of activity in the field of biotechnology, also it enables a comparison across geographic regions http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD06-00-01-00-00 Thu, 29 Dec 2011 08:25:37 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD06-00-01-00-00 Market Engineering Research Service This research service provides an analysis of various aspects of the molecular diagnostics market in Europe for the years 2007 - 2015. The market has been divided into four segments: infectious diseases, genetic diseases, oncology and pharmacogenomics. The market has been covered segment wise, as well as geography wise, covering seven countries and regions. A detailed analysis of competitive landscape has been presented. The research service highlights main drivers and restraints for the market growth as well as key trends in the molecular diagnostics market for the period from 2011 to 2015. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72C-01-00-00-00 Wed, 28 Dec 2011 04:40:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72C-01-00-00-00 Market Engineering Research Service The Research Service aims to analyse and assess the European Thrombosis Therapeutics Market, by analysing the key trends and dynamics shaping the industry sector in co-relation with the market drivers and restraints. With several key blockbuster drugs losing patent protection and new Healthcare Reforms introduced by the Governments, the Thrombosis market employs different trends to keep the market growing at a fairly steady phase. This study provides an in depth knowledge of the key European markets by presenting significant growth opportunities for the existing and the pipeline drugs with their impacts over a period of time. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M74C-01-00-00-00 Tue, 27 Dec 2011 22:03:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M74C-01-00-00-00 Market Engineering Research Service The primary objective of this study is to measure brand perceptions of tools and technologies currently at the forefront of stem cell research: bio-imaging and microscopy, cell biology tools, immunochemicals, molecular biology tools, and protein biochemistry tools. The study also looks into the usage pattern of these tools. An extensive end-user survey was conducted with 25 laboratories to assess the requirement and usage of tools. Insightful review of key industry drivers, restraints and challenges have been discussed. Leading market players and the prevailing competitive landscape for each of the segments have been discussed. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72F-01-00-00-00 Tue, 27 Dec 2011 07:57:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72F-01-00-00-00 Market Engineering Research Service The research service aims to analyse and assess the global generics pharmaceutical market, map the key trends and dynamics shaping the industry sector and provide strategic recommendations for the success of the market participants. With several key blockbuster drugs losing patent protection and new healthcare reforms being introduced by the Governments, the generics pharmaceutical market is on a growing curve. This study provides an in-depth knowledge of the key national markets and therapeutic areas presenting significant growth opportunities for generics, consolidation trends in the industry and impact of regulation on each of the markets. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M74E-01-00-00-00 Fri, 23 Dec 2011 22:54:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M74E-01-00-00-00 Market Engineering Research Service The U.S. anticoagulant market is on the verge of a potential major shift in clinical practice, from a market dominated by a single injectable anticoagulant to a highly competitive market dominated by first-in-class novel oral anticoagulants. While these novel oral agents are expected to become standard of care for stroke prevention in atrial fibrillation patients, injectable agents will likely maintain their hold on certain hospital-based critical care applications. This research service covers the U.S. anticoagulant market from 2008 to 2016, with 2010 as the base year. Included are products on the market, products in development, and patient and revenue forecasts. Market challenges, drivers and restraints are identified and assessed. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N9EF-01-00-00-00 Tue, 20 Dec 2011 10:35:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N9EF-01-00-00-00 Market Engineering Research Service The aim of this research study is to thoroughly assess and analyse the biosimilars market, as well as market and technology trends in Europe, in order to provide strategic recommendations for the success of market participants. This study is focused on established segments in Europe including Erythropoietin, Granulocyte Colony Stimulating Factors, Human Growth Hormones and emerging segments including monoclonal antibodies, Insulin and interferon. The established market segments consist of products currently approved and marketed in Europe. New therapeutic classes of drugs are expected to be a major contributor in the emerging market segments. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M770-01-00-00-00 Tue, 20 Dec 2011 09:34:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M770-01-00-00-00 Technical Insights Alert This issue profiles using an anti-telomerase therapy for drug-resistant mature or stem cancer cells, using carbohydrate mimetic peptide as an effective drug delivery vehicle, and using ellipticine compounds as anti-obesity small molecule therapeutics. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-39-00-00 Fri, 16 Dec 2011 05:28:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-39-00-00 Market Engineering Research Service The Research Service offers analysis and assessment of the European Pharmaceutical and Biotech Contract Manufacturing Markets, maps the key trends and dynamics shaping the industry sector, and provides strategic recommendations for the success of the market participants. This study provides an in-depth analysis of the Pharmaceutical Contract Manufacturing Market in terms of Solids, Liquids, and Injectables finished dose formulations; and the Biotech Contract Manufacturing Market, in terms of Mammalian and Microbial cell culture based products, with a specific focus on the key five countries in Europe - Germany, France, the United Kingdom, Italy, and Spain. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M78C-01-00-00-00 Thu, 15 Dec 2011 22:38:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M78C-01-00-00-00 Technical Insights Alert This issue profiles applying quartz crystal microbalance for small pox virus detection, an antibody-based gene therapy for HIV infections, diagnostic kits using blood samples and biomarker testing for early disease detection. Strategic partnership details and some important patents have also been included. http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7A-00-00 Fri, 9 Dec 2011 03:57:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7A-00-00 Customer Research The U.S. biosimilars market is a fast approaching reality. However, much uncertainty lies ahead, including the market potential as a function of physician adoption of biosimilars. This panel discussion was conducted to preview the thoughts and expectations of specialty physicians who would be expected to be among the first customers of biosimilars, with the objective of gaining insight into some of the major factors which could influence market uptake. The research for this service was gathered from a panel consisting of 20 pre-selected specialty physicians and was conducted via online moderated discussion boards over a three-day period. Key findings, qualitative analyses and recommendations are included. http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=NA7B-01-00-00-00 Thu, 8 Dec 2011 07:44:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=NA7B-01-00-00-00